Eptinezumab treatment reduces monthly migraine days and acute medication use in patients with difficult-to-treat episodic or chronic migraine.

Lasmiditan is safe and effective in acute migraine, underscoring the importance of continued development of this medication class.

Researchers conducted a systematic review and meta-analysis evaluating the potential association between endometriosis and migraine.

For-profit hospital status was associated with worse patient and nurse outcomes, partially because of differences in nurse staffing.

Medical cannabis seemed to have little to no meaningful effect on quality of sleep, total sleep time, or daytime functioning in adults with insomnia.

Pilot trial data indicated structured support interventions attenuate weight gain in adults stopping GLP-1 RA medication.

Using NSAIDs, opioids, and acetaminophen for osteoarthritis management can lead to multiple incident chronic conditions.

High perceived comfort with migraine treatments and symptom control are linked to fewer monthly headache days and reduced ...

EArly axSpA, with duration of no more than 2 years of axial symptoms, was associated with lower long-term spinal structural damage.

A Massachusetts man pleaded guilty to money laundering conspiracy in a Medicare fraud scheme involving unnecessary medical braces.

Longer sleep duration was associated with an increased risk for incidence and progression of diabetic nephropathy in type 2 diabetes.

Hypnosis provides a modest reduction in clinical pain intensity compared with nonactive controls but does not outperform other psychological therapies.